Dr. Thrower is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Andrew C. Carlos MS Institute Shepherd
2020 Peachtree Rd NW
Atlanta, GA 30309Phone+1 404-352-2020
Education & Training
University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of MedicineResidency, Neurology, 1989 - 1992- University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of MedicineInternship, Internal Medicine, 1988 - 1989
University of Florida College of MedicineClass of 1988
Certifications & Licensure
GA State Medical License 2001 - 2025
WA State Medical License 1992 - 2002
TX State Medical License 1990 - 1992- American Board of Psychiatry and Neurology Neurology
Clinical Trials
- Safety and Efficacy of AVP-923 in the Treatment of Central Neuropathic Pain in Multiple Sclerosis Start of enrollment: 2011 Sep 08
- Study of Fampridine-ER Tablets in Patients With Multiple Sclerosis Start of enrollment: 2011 Mar 01
Publications & Presentations
PubMed
- 87 citationsClinically isolated syndromes Predicting and delaying multiple sclerosisBen W. Thrower
Neurology. 2007-06-12 - 245 citationsRecommendations for cognitive screening and management in multiple sclerosis careRosalind Kalb, Meghan Beier, Ralph H.B. Benedict, Leigh Charvet, Kathleen Costello
Multiple Sclerosis. 2018-10-10 - 9 citationsEffect of dimethyl fumarate on lymphocyte subsets in patients with relapsing multiple sclerosisGuy J. Buckle, Daniel S. Bandari, Jeffrey Greenstein, Mark Gudesblatt, Bhupendra O. Khatri
Multiple Sclerosis Journal - Experimental, Translational and Clinical. 2020-04-29
Press Mentions
How B-cell Therapy Affects MSFebruary 7th, 2023- How Pregnancy Affects Multiple Sclerosis (MS), According to ExpertsOctober 6th, 2022
- ImStem Announces First US Multiple Sclerosis Patient Has Been Dosed with Its IMS001November 18th, 2021
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
